New baby formula aims to boost brain power in infants
NCT ID NCT06475521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new infant formula helps healthy babies grow and develop their brains as well as standard formula or breast milk. About 579 healthy, full-term newborns will be fed either the new formula, a standard formula, or breast milk for up to 52 weeks. Researchers will measure weight gain and use a standard test of thinking and learning skills at one year of age.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
new infant formula
What this could lead to
If successful, this could show that the new formula supports normal growth and may improve early brain development in formula-fed babies.
What could go wrong
This is an early-stage study in healthy infants, so results may not apply to all babies. The brain development benefit is a secondary goal and may not be proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BABY FORMULA, GROWTH EQUIVALENCE, NEUROCOGNITIVE DEVELOPMENT, HEALTHY INFANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gyncentrum Spółka Z Ograniczoną Odpowiedzialnością,
Katowice, Lesser Poland Voivodeship, 40-851, Poland
-
Medical Centre Asklepiy OOD Dupinista
Dupnitsa, 2600, Bulgaria